Disease

Hypertension

Review Report on Hypertension Target / Biomarker Content of Review Report on Hypertension Target / Biomarker
Hypertension


About the Disease
Hypertension, Essential, also known as essential hypertension, is related to pulmonary hypertension and renovascular hypertension, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Hypertension, Essential is PTGIS (Prostaglandin I2 Synthase), and among its related pathways/superpathways are Development Angiotensin activation of ERK and "Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics". The drugs Digoxin and Warfarin have been mentioned in the context of this disorder. Affiliated tissues include heart, kidney and eye, and related phenotypes are elevated systolic blood pressure and elevated diastolic blood pressure

Common Targets
P18508 | G1 | G5409 | G9536 | G148 | G1187 | G259249 | G5468 | G7276 | G7352 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | G5789 | G23533 | G3294 | cAMP Phosphodiesterase (nonspecified subtype) | P32835 | G6548 | G7150 | G58508 | G3782 | G5028 | G9776 | G5879 | G64078 | G6764 | G116511 | G1312 | P36692 | G139760 | G558 | G59272 | G6571 | G80298 | G1268 | G2053 | G2100 | G83447 | G3350 | G4128 | G716 | G7376 | G22901 | G6530 | G23150 | G51738 | P32836 | G5293 | G89866 | G9943 | Alpha-2 Adrenergic receptors (nonspecified subtype) | G1950 | G7442 | G84876 | G200186 | G1188 | Serine/Threonine Kinase (nonspecified subtype) | G80339 | G2908 | G116512 | G1408 | G1489 | G4543 | G7299 | G8694 | G2864 | G5778 | G6093 | G142 | G29119 | G6778 | G5016 | G3752 | G217 | Phosphodiesterase 1 (PDE1) (nonspecified subtype) | G1586 | G406 | G4314 | G5321 | G2784 | G5578 | G11188 | Lipoxygenase (nonspecified subtype) | G151 | G6559 | G183 | G1902 | G4576 | G5733 | G7295 | G763 | G3065 | G91703 | G11093 | G1128 | G5029 | G55105 | G9370 | G5739 | G9817 | G9970 | G3426 | G22937 | G2832 | G5742 | G339768 | G203228 | G598 | Estrogen receptor (nonspecified subtype) | G2099 | G4524 | G23224 | G101927825 | G846 | G105370676 | G3156 | G113026 | G5291 | G9172 | G6656 | G2217 | P11019 | G1589 | G22834 | G759 | G25970 | Endothelin-Converting Enzymes (ECE) (nonspecified subtype) | G116519 | P6320 | G4286 | G4886 | G5241 | G5290 | G553 | G5743 | Glycogen phosphorylase (nonspecified subtype) | G43 | G79698 | G79927 | G25890 | G3357 | G134 | G3772 | DNA Topoisomerase II (nonspecified subtype) | G23411 | G3383 | G187 | G239 | G5243 | G283208 | G9429 | G3479 | P6463 | Neuropeptide Y receptor (NPY-R) (nonspecified subtype) | Acid-Sensing Ion Channel (ASIC) (nonspecified subtype) | G191 | G140469 | G8824 | G6296 | G6319 | P40594 | G80895 | G2645 | G100126793 | G136 | G1536 | G1543 | G728434 | G2324 | G54901 | G650 | G5024 | G51393 | G887 | G3360 | G1859 | G100873946 | G8913 | G5880 | Kir 3.1/3.4 | G7357 | G50854 | G8841 | G55107 | G5600 | G132320 | cGMP-Dependent Protein Kinase (nonspecified subtype) | G1956 | G771 | G23327 | G50624 | G8600 | G3290 | Steroid 5-alpha-Reductase (nonspecified subtype) | G2321 | G6446 | P6884 | G4318 | G5137 | G29102 | G116085 | G765 | G4940 | G100048912 | G285973 | G93550 | G5782 | G3630 | G3739 | Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | G441639 | G4535 | G2671 | G6753 | G801 | G3061 | G11213 | G5152 | G119032 | Small Conductance Calcium-Activated Potassium Channel (SK) (nonspecified subtype) | G6338 | alpha-Adrenoceptor (nonspecified subtype) | G7046 | G729230 | G5077 | G135 | G6563 | G1621 | G51179 | G5481 | G6850 | G19 | G7421 | G2776 | G1176 | G60676 | G383 | G1803 | G4519 | G2250 | G6648 | G2078 | G2138 | G5030 | G50507 | G5527 | Sodium channel (nonspecified subtype) | Acetylcholine Receptors (Nicotinic) (nAChR) (nonspecified subtype) | G4158 | G5205 | G2702 | G5467 | G10628 | Cholesterol esterase (nonspecified subtype) | G3758 | G3783 | G2159 | G8698 | G8856 | G1139 | cGMP Phosphdiesterase (PDE) (nonspecified subtype) | G231 | G8942 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) (nonspecified subtype) | G3795 | G775 | G4688 | G255738 | G9294 | G2952 | G4773 | G7498 | Opioid receptor (nonspecified subtype) | G6550 | G204010 | G554 | G9356 | G5770 | G10266 | G93974 | G3189 | G150 | G4846 | G590 | G3791 | P16126 | P24881 | G6521 | G2658 | G2932 | G3248 | Guanylate cyclase (nonspecified subtype) | G339896 | G350 | Peroxisome Proliferator-Activated Receptors (PPAR) (nonspecified subtype) | G5020 | G3480 | G167691 | G1191 | G367 | G155 | G7412 | G4887 | G5054 | Chloride channel (nonspecified subtype) | G221785 | G127733 | G6300 | G3067 | G632 | G2494 | G10747 | P19243 | Neuromedin U Receptor (nonspecified subtype) | G1910 | G24144 | G2243 | G2316 | G100130207 | G345 | P16176 | G54790 | P6278 | G6943 | G57674 | G836 | G55829 | G65266 | G4689 | G22987 | G23405 | G1066 | G1591 | Adenylate Cyclase (nonspecified subtype) | G4985 | G53345 | G3375 | Calcium-Activated K(Ca) Potassium Channel (nonspecified subtype) | G81624 | G6597 | G4987 | G51422 | G6329 | G81494 | G10267 | G118 | G1511 | G7433 | G5740 | G3553 | Myosin Class II (nonspecified subtype) | G162282 | G4313 | G2837 | Kir 3.1/3.2 | Mitogen-Activated Protein Kinase (nonspecified subtype) | G100 | G2696 | G54986 | G64478 | G1903 | G766 | G65267 | G4159 | G10877 | P34664 | G66005 | G140 | G3569 | G6340 | Integrin alphaIIbbeta3 (fibrinogen gpIIb/IIIa) receptor | G408187 | G219621 | G5166 | G5340 | Platelet-Derived Growth Factor Receptor (nonspecified subtype) | Adenosine deaminase (nonspecified subtype) | G6532 | G9140 | G9376 | G5734 | G125 | P5867 | G377677 | G6582 | G4734 | G286046 | G5836 | G3356 | G3934 | G1634 | G2867 | G4316 | G8654 | G10268 | G9620 | G10878 | G6262 | G4878 | G23189 | G2322 | G10847 | G57403 | G338821 | G7422 | G490 | K(ATP) Channel (nonspecified subtype) | G3760 | Na+/K+-ATPase (nonspecified subtype) | G5079 | G3741 | G65268 | G160335 | G7010 | G719 | G2264 | G1577 | G153 | G84517 | G53347 | G5729 | G113263 | 15-Lipoxygenase (nonspecified subtype) | G706 | G4311 | G857 | G3552 | G1812 | G5583 | G23269 | G23365 | G100379251 | G6660 | G6833 | G2185 | G5580 | G571 | G120227 | G4350 | G2166 | G27030 | G3558 | G1994 | G284486 | G3062 | G65125 | G4620 | G4889 | Trypsin (nonspecified subtype) | G164781 | G5034 | G100528007 | beta-Adrenoceptor (nonspecified subtype) | G2194 | G4633 | G2538 | G10060 | G5540 | Elastase (nonspecified subtype) | G132789 | G157273 | G2244 | P6348 | G8989 | G5617 | G57101 | G9821 | G144132 | G2153 | G4843 | G4553 | G51750 | G283748 | G3458 | Prostanoid TP receptor (nonspecified subtype) | G6773 | G4738 | G10203 | G4879 | G53831 | G2868 | G1544 | G3990 | G445 | G3953 | G412 | G5156 | G8876 | G3269 | G3777 | G185 | G51094 | G2878 | sigma Receptor (nonspecified subtype) | G7015 | G219790 | G497258 | G10159 | G356 | Cysteine Protease (nonspecified subtype) | G8792 | G56670 | P11025 | G6335 | Triacylglycerol Lipase (TG Lipase) (nonspecified subtype) | G4052 | G7076 | G3717 | G282980 | G104909134 | G1394 | G3762 | G152273 | G378938 | G1727 | G196 | G776 | G4923 | G55757 | G9475 | G1080 | G154 | G5138 | G2982 | G57510 | G5947 | G6649 | G57537 | G146 | Dopamine receptor (nonspecified subtype) | L-Type calcium channel (nonspecified subtype) | P6058 | G50508 | G5153 | G5216 | G6927 | G5901 | P18298 | G160418 | G5140 | G3362 | G7428 | G1559 | G2043 | G2548 | G2778 | HTR1B | G1573 | G1906 | G760 | G29904 | G7296 | G100288077 | G105371702 | G22854 | G23194 | G2358 | G2944 | G5289 | 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) | Muscarinic Acetylcholine Receptor (mAChR) (nonspecified subtype) | G7124 | G4638 | Organic anion transporters (OATs) (nonspecified subtype) | alpha1-Adrenoceptor (nonspecified subtype) | 17-beta-Hydroxysteroid dehydrogenase (nonspecified subtype) | P2X Receptor (nonspecified subtype) | G644890 | G2219 | G5444 | G54920 | Sterol O-acyltransferase (ACAT) (nonspecified subtype) | P13024 | P15736 | Histone deacetylase (nonspecified subtype) | G406938 | G3291 | P16740 | G623 | G3908 | G4047 | G2027 | G133 | G56683 | G467 | G79400 | G348 | Vasopressin Receptor (nonspecified subtype) | G6523 | Cyclooxygenase (COX) (nonspecified subtype) | G773 | G27346 | G54822 | Gastric H+/K+-ATPase | G768 | G5781 | G3358 | G4508 | G3576 | G51185 | G114548 | G8170 | G8877 | G7054 | G2028 | G2869 | G5300 | G84909 | G54212 | G128 | G3763 | Cannabinoid receptor (nonspecified subtype) | G406996 | G718 | G100616147 | Adenosine receptor (nonspecified subtype) | G1588 | G170691 | G6853 | G4160 | G7369 | G32 | P24924 | G3899 | G680 | G1814 | G27035 | G177 | G2199 | G23345 | G5328 | G5602 | G165186 | G186 | G104384744 | G4624 | G9149 | G2984 | G3075 | Nitric oxide synthase (NOS) (nonspecified subtype) | G41 | G22953 | G240 | G55139 | G57016 | G131578 | G3818 | G26279 | G8645 | G27302 | G3146 | G6347 | Urea transporter (nonspecified subtype) | G7148 | G79068 | G5422 | G9340 | Carbonic Anhydrase V (nonspecified subtype) | G101929710 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | G5027 | G23408 | G1889 | G5045 | G9365 | Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | G8529 | G5648 | Phospholipase A2, Secretory (sPLA2) (nonspecified subtype) | G596 | G6531 | G7768 | G100505549 | Calcium-activated chloride channel regulators (nonspecified subtype) | Potassium Channels (nonspecified subtype) | G4881 | G23632 | G2740 | G5754 | 5-Hydroxytryptamine Receptor (nonspecified subtype) | G7157 | G64839 | G2831 | G9290 | G170692 | G7040 | G2149 | G10699 | Arginase (nonspecified subtype) | Endothiapepsin (nonspecified subtype) | G3764 | G2317 | G54932 | Myosin (nonspecified subtype) | Angiotensin receptor (AT) (nonspecified subtype) | G3991 | G7099 | G5294 | G284 | G3779 | G4142 | G5021 | G10019 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | G4129 | G4745 | G25 | G6427 | G81926 | Endothelin receptor (nonspecified subtype) | G3736 | G221935 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | Sterol Regulatory Element-Binding Protein (nonspecified subtype) | G1585 | G406973 | NADPH Oxidase (nonspecified subtype) | G127435 | G735 | G47 | G3162 | Aurora Kinase (nonspecified subtype) | P10999 | Tryptophan 5-Monooxygenase (nonspecified subtype) | Rho kinase (ROCK) (nonspecified subtype) | G1901 | G338442 | G1401 | G147 | G26011 | G6331 | G8435 | G8862 | G983 | G114781 | G5896 | G6774 | G54800 | Neurotensin receptor (nonspecified subtype) | G3606 | G143872 | G4048 | G6934 | G7048 | G105370003 | G149233 | alpha-Amylase (nonspecified subtype) | G4509 | G799 | G27347 | G56729 | P34550 | G4540 | G79798 | G3283 | G1129 | G259230 | G1141 | G1407 | G4864 | G23564 | G290 | G64421 | G3766 | G1579 | G2034 | G148641 | G1524 | G1594 | G2030 | G5972 | G7350 | G5266 | G31 | G5788 | G59340 | G2863 | G580 | G5997 | G6585 | Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | G102723321 | G23410 | G5592 | G7804 | G107985578 | G5724 | G10891 | P5859 | G4353 | G5136 | G144453 | G156 | G5547 | G134864 | G50943 | G257169 | G3481 | G1395 | G6647 | G4988 | P36339 | G761 | G10013 | G3091 | Superoxide dismutase (SOD) (nonspecified subtype) | G1215 | P16192 | G64072 | G4882 | G115 | G5230 | G8863 | G9033 | G3352 | G387 | G221955 | G574501 | G6311 | G1909 | G11318 | Ribosomal Protein S6 Kinase, 70kDa (p70S6K) (nonspecified subtype) | Phosphodiesterase (nonspecified subtype) | G152 | G1636 | G8974 | G6097 | Vasopressin V1 Receptor (nonspecified subtype) | Imidazoline receptor (nonspecified subtype) | G1576 | G1630 | G4179 | G9388 | G5139 | G246 | G5586 | G627 | G102723487 | G3363 | G147968 | G5168 | G54805 | G55244 | G105370115 | G3620 | G6546 | G2169 | Bradykinin receptor (nonspecified subtype) | G4057 | G4986 | G5538 | G3066 | G6517 | G2642 | G91662 | G11255 | G3593 | G6401 | G3708 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | G6916 | G9533 | G1535 | P6747 | G1991 | G80036 | G9982 | G254827 | G9252 | G9718 | G1113 | G10451 | G1269 | G6326 | G7222 | G4780 | G23144 | G552 | G9863 | Monoamine oxidase (MAO) (nonspecified subtype) | G7494 | G6557 | G717 | G3949 | G10607 | G1674 | G5320 | G1012 | G1509 | G6524 | G151306 | Epoxide Hydrolase (nonspecified subtype) | P32831 | G1380 | G3767 | Interleukin 17 (nonspecified subtype) | G407002 | G207 | G283450 | G1948 | G762 | G120892 | G64428 | Acetyl-CoA Carboxylases (ACC) (nonspecified subtype) | Carbonic Anhydrase (nonspecified subtype) | G624 | G3751 | G8912 | G1813 | G4982 | G5122 | G5142 | G55328 | G5820 | G3757 | G154215 | G7881 | G2859 | G112399 | Na+/H+ Exchanger (NHE) (nonspecified subtype) | G4306 | G1071 | G10841 | G338557 | CCK receptor (nonspecified subtype) | G1557 | G6720 | G1644 | G100996758 | G3077 | G154664 | G4571 | G774 | G2475 | G829 | G5159 | G100533464 | G54897 | G89858 | G11132 | G1281 | G629 | G4868 | G5465 | Heat shock protein 90 (nonspecified subtype) | G731 | G5550 | G1021 | G92291 | Phosphodiesterase 6 (PDE6) (nonspecified subtype) | G55553 | Prostanoid Receptor (nonspecified subtype) | G1445 | G4627 | G4753 | G4883 | G8078 | G105370438 | G105377304 | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | G6580 | G221692 | G2693 | G132 | Calcium channel (nonspecified subtype) | G6558 | G79054 | Protein kinase C (nonspecified subtype) | G4023 | G7450 | G84867

The "Target / Biomarker Review Report" is a comprehensive and customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about the Target(s) / Biomarker(s) of your choice related to Hypertension, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

Other Diseases

Hypertension, Essential | Hypertension, Portal | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hypertensive Nephropathy | Hypertensive Retinopathy | Hyperthermia, Malignant | Hyperthyroidism | Hypertriglyceridemia | Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive 1 | Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive 2 | Hypertrophy | Hyperuricemia | Hyperuricemic Nephropathy, Familial Juvenile | Hypervalinemia | Hypoalbuminemia | Hypobetalipoproteinemias | Hypocalcemia | Hypodontia | Hypogammaglobulinemia | Hypoglycemia | Hypogonadism | Hypohidrotic Ectodermal Dysplasia | Hypohidrotic Ectodermal Dysplasia, X-linked | Hypokalemia | Hypokalemic Periodic Paralysis | Hypolipoproteinemia | Hypomyelination With Atrophy Of Basal Ganglia And Cerebellum | Hypoparathyroidism | Hypophosphatasia | Hypophosphatemic Rickets With Hypercalciuria, Hereditary | Hypophosphatemic Rickets, Autosomal Recessive, 1 | Hypopigmentation | Hypopituitarism | Hypoplastic Left Heart Syndrome | Hypoproteinemia, Hypercatabolic | Hypospadias | Hypotension, Orthostatic | Hypothalamic Obesity | Hypothyroidism | Hypotonia-cystinuria Syndrome | Hypotrichosis | Hypotrichosis Simplex | Hypotrichosis, Congenital, With Juvenile Macular Dystrophy | ICF Syndrome | Ichthyosis | Ichthyosis Bullosa Of Siemens | Ichthyosis Hystrix, Curth-Macklin Type | Ichthyosis, X-linked | Idiopathic Multicentric Castleman Disease | Idiopathic Pulmonary Fibrosis | IgA Deficiency | IgA Nephropathy | Ileitis | IMAGe Syndrome | Imerslund-Grasbeck Syndrome | Immunoproliferative Disorders | Impetigo | Impulse Control Disorder | Inborn Errors Of Metabolism | Incontinentia Pigmenti | Infantile Liver Failure Syndrome 1 | Infantile Nephropathic Cystinosis | Infantile Neuroaxonal Dystrophy | Infantile Refsum Disease | Infantile Spasm | Infectious Diarrhea | Infertility | Infertility, Male | Inflammatory Bowel Disease | Inflammatory Joint Disease | Inflammatory Linear Verrucous Epidermal Nevus | Inflammatory Myofibroblastic Tumor | Inflammatory Myopathy | Influenza | Insulin Resistance | Insulinoma | Intellectual Disability, Autosomal Dominant 5 | Intermittent Claudication | Intermittent Explosive Disorder | Interstitial Lung Diseases | Intestinal Hypomagnesemia 1 | Intestinal Obstruction | Intestinal Pseudo-obstruction | Intestinal Tuberculosis | Intracerebral Hemorrhage | Intracranial Hypertension | Iron Deficiency Anemia | Iron Metabolism Disorders | Iron Overload | Irritable Bowel Syndrome | Ischemia | Isobutyryl-CoA Dehydrogenase Deficiency | Isovaleric Acidemia | Jacobsen Syndrome | Jalili Syndrome | Japanese Encephalitis | Jaundice, Obstructive | Jawad Syndrome | Johanson-Blizzard Syndrome | Joubert Syndrome | Joubert Syndrome 2 | Juvenile Hyaline Fibromatosis | Juvenile Myelomonocytic Leukemia | Juvenile Myoclonic Epilepsy | Juvenile Polyposis | Juvenile Xanthogranuloma | Kabuki Syndrome | Kabuki Syndrome 2 | Kallmann Syndrome | Kaposi Sarcoma | Kaposiform Hemangioendothelioma | Kashin-Beck Disease | Kawasaki Disease | KBG Syndrome | Kearns-Sayre Syndrome | Keloid | Keratitis | Keratitis-ichthyosis-deafness Syndrome | Keratoacanthoma | Keratoconjunctivitis | Keratoconus | Keratocystic Odontogenic Tumor | Keratopathy | Keratosis | Keratosis, Actinic | Keratosis, Seborrheic | Kernicterus | Kidney Stones | Kindler Syndrome | Kleine-Levin Syndrome | Klinefelter Syndrome | Klippel-Feil Syndrome | Knobloch Syndrome | Kohlschutter-Tonz Syndrome | Krabbe Disease | L-2-Hydroxyglutaric Aciduria | Lactose Intolerance | Lafora Disease | Lamellar Ichthyosis | Language Disorders | Large Granular Lymphocytic Leukemia | Larsen Syndrome | Lassa Fever | Lateral Meningocele Syndrome | Lathosterolosis | Lattice Corneal Dystrophy | Lattice Corneal Dystrophy Type 1 | Learning Disability | Leber Congenital Amaurosis | Leber Hereditary Optic Neuropathy | Left Ventricular Noncompaction | Leigh Syndrome | Leiomyoma | Leiomyosarcoma | Leishmaniasis, Cutaneous | Leishmaniasis, Visceral | Lennox-Gastaut Syndrome | Lentigo | LEOPARD Syndrome | Leprosy | Leri Pleonosteosis | Leri-Weill Dyschondrosteosis | Lesch-Nyhan Syndrome | Leukemia | Leukemia-lymphoma, Adult T-cell | Leukocyte Adhesion Deficiency | Leukocyte Adhesion Deficiency Type 1 | Leukodystrophies | Leukoencephalopathy, Progressive Multifocal | Leukoplakia | Leukoplakia, Oral | Lewy Body Dementia | Li-Fraumeni Syndrome | Lichen Planus | Lichen Sclerosus | Liddle Syndrome | Liebenberg Syndrome | Light Chain Amyloidosis | Ligneous Conjunctivitis | Limb Girdle Muscular Dystrophy | Lipid Metabolism Disorders | Lipid Storage Diseases | Lipid Storage Myopathy | Lipodystrophy | Lipoma | Lissencephaly 2 | Liver Diseases | Liver Failure | Liver Failure, Acute Infantile | LMNA-related Congenital Muscular Dystrophy | Localized Scleroderma | Loeys-Dietz Syndrome | Loeys-Dietz Syndrome Type 4 | Long QT Syndrome Type 1 | Long QT Syndrome Type 2 | Long QT Syndrome Type 3 | Long-chain 3-hydroxyacyl-coenzyme A Dehydrogenase Deficiency | Low Phospholipid Associated Cholelithiasis | Low Tension Glaucoma | LRBA Deficiency | Lung Diseases | Lupus Erythematosus | Lyme Disease | Lymphangioleiomyomatosis | Lymphangioma | Lymphangiomatosis | Lymphedema | Lymphedema-distichiasis Syndrome | Lymphoma | Lymphoma Lymphoblastic | Lymphoma, AIDS-related | Lymphoma, B-cell | Lymphoma, Follicular | Lymphoma, Mantle Cell | Lymphoma, Primary Cutaneous Anaplastic Large Cell | Lymphomatoid Granulomatosis | Lymphopenia | Lymphoproliferative Disease, X-linked | Lymphoproliferative Disorders | Lysosomal Acid Lipase Deficiency | Mabry Syndrome | Macrodactyly | Macrophage Activation Syndrome | Macrophagic Myofasciitis | Macular Corneal Dystrophy | Macular Corneal Dystrophy Type 1 | Macular Degeneration | Majeed Syndrome | Major Depression | Malaria | Malaria, Cerebral | Malignant Fibrous Histiocytoma | Malignant Peripheral Nerve Sheath Tumor | Malnutrition | Malonyl-CoA Decarboxylase Deficiency | Mandibuloacral Dysplasia With Type A Lipodystrophy | Mannosidase Deficiency Diseases | Maple Syrup Urine Disease | Marfan Syndrome | Marinesco-Sjogren Syndrome | Marshall-Smith Syndrome | Martsolf Syndrome | Mast Cell Leukemia | Mastitis | Maternally Inherited Diabetes And Deafness | McCune-Albright Syndrome | McKusick Type Metaphyseal Chondrodysplasia | McLeod Syndrome | Measles | Meckel-Gruber Syndrome | Meconium Ileus | Medium-chain Acyl-CoA Dehydrogenase Deficiency | Medulloblastoma | Meesmann Corneal Dystrophy | Megacystis-microcolon-intestinal Hypoperistalsis Syndrome | Megalencephaly | Megaloblastic Anemia | Meier-Gorlin Syndrome | Melanocytic Nevus | Melanoma | Melanoma, Malignant | Melanoma, Uveal | MELAS Syndrome | Meleda Disease | Melnick-Needles Syndrome | Membranous Nephropathy | Menetrier Disease | Meniere's Disease | Meningeal Melanocytoma | Meningioma | Meningioma, Benign | Meningitis | Meningococcal Infections | Meningococcal Meningitis | Menkes Disease | Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis | Mesothelioma, Malignant | Metabolic Diseases | Metabolic Syndrome | Metachondromatosis | Metachromatic Leukodystrophy | Metanephric Adenoma | Metaphyseal Chondrodysplasia, Schmid Type | Metatropic Dysplasia | Methemoglobinemia | Methemoglobinemia Type IV | Methylmalonic Acidemia | Methylmalonic Aciduria And Homocystinuria, CblC Type | Mevalonate Kinase Deficiency | Micro Syndrome | Microcephalic Osteodysplastic Primordial Dwarfism, Type I | Microcephalic Osteodysplastic Primordial Dwarfism, Type II | Microcephalic Primordial Dwarfism | Microcephaly | Microcephaly, Seizures, And Developmental Delay | Micropenis | Microphthalmia | Microphthalmia, Syndromic 7 | Microtia | Microvillus Inclusion Disease | Migraine | Milk Allergy | MIRAGE Syndrome | Mitochondrial Cytopathy | Mitochondrial Disease | Mitochondrial DNA Depletion Syndrome | Mitochondrial DNA Depletion Syndrome 13 | Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form | Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form | Mitochondrial DNA Depletion Syndrome, Myopathic Form | Mitochondrial Encephalomyopathy | Mitochondrial Myopathy | Mixed Connective Tissue Disease | Miyoshi Myopathy | Mohr-Tranebjaerg Syndrome | Molybdenum Cofactor Deficiency | Monilethrix | Mood Disorder | Mosaic Variegated Aneuploidy Syndrome 2 | Motion Sickness | Motor Neuron Diseases | Mountain Sickness | Moyamoya Disease | Muckle-Wells Syndrome | Mucolipidosis | Mucolipidosis Type II | Mucolipidosis Type III | Mucolipidosis Type IV | Mucormycosis | Muir-Torre Syndrome | Multicentric Carpotarsal Osteolysis Syndrome | Multicystic Renal Dysplasia | Multifocal Motor Neuropathy | Multiple Congenital Anomalies-hypotonia-seizures Syndrome 2 | Multiple Epiphyseal Dysplasia | Multiple Hamartoma Syndrome | Multiple Mitochondrial Dysfunctions Syndrome Type 1 | Multiple Myeloma | Multiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapsing-remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sulfatase Deficiency | Multiple System Atrophy | Multisystemic Smooth Muscle Dysfunction Syndrome | Mumps | Muscle Wasting | Muscular Dystrophy | Myasthenia | Myasthenia Gravis | Mycosis Fungoides | Myelitis | Myelitis, Transverse | Myelodysplasia | Myelofibrosis | Myeloid Leukemia | Myelomeningocele | Myhre Syndrome | Myocardial Infarction | Myocarditis | Myoclonic Atonic Epilepsy | Myoclonic Epilepsy With Ragged Red Fibers | Myoclonus | Myoclonus-dystonia Syndrome | Myofibrillar Myopathy | Myofibromatosis | Myopathy | Myopia | Myosin Storage Myopathy | Myositis | Myositis, Focal | Myotonia | Myotonic Disorders | N-acetylglutamate Synthase Deficiency | Nager Acrofacial Dysostosis | Nail Disorder, Nonsyndromic Congenital | Nail-Patella Syndrome | Nance-Horan Syndrome | Nanophthalmos | Narcolepsy | Nasodigitoacoustic Syndrome | NDH Syndrome | Necrobiosis Lipoidica | Necrotizing Autoimmune Myopathy | Nemaline Myopathy | Nemaline Myopathy 10 | Nemaline Myopathy 8 | Neonatal Progeroid Syndrome | Neovascular Glaucoma | Nephritis, Interstitial | Nephroblastoma | Nephrocalcinosis | Nephronophthisis | Nephropathy | Nephrosclerosis | Nephrotic Syndrome | Nephrotic Syndrome Type 1